Release of Next-Generation IB Clinic

Imaging Biometrics, Ltd

("IBAI" or the "Company")

Imaging Biometrics Announces Release of Next-Generation IB Clinic

Imaging Biometrics, LLC, ("IB"), a leader in advanced quantitative imaging solutions, is pleased to announce the release of the next version of IB Clinic, its comprehensive image processing suite featuring renowned products such as IB Neuro, IB DCE, IB Rad Tech, and others. The release marks a significant leap forward in automation, scalability, workflow integration and customization across its imaging technologies.

This release delivers true hands-free, platform-independent functionality, transforming IB's proven and quantitative imaging technologies into a fully automated environment that saves time and reduces manual steps. By consolidating nearly all IB plugin capabilities into one streamlined solution, IB Clinic eliminates workflow bottlenecks, minimizes user intervention, and ensures consistent, reproducible results with its exclusive standardization technology. Clinicians can now focus on interpretation and patient care rather than technical setup, while integrated third-party applications enable seamless access to complementary tools-all within a single platform. This level of automation and interoperability accelerates decision-making, improves reporting efficiency, and supports collaboration across clinical, research, and commercial settings.

Through IB's quantitative tools and fully customizable workflows, clinicians and researchers can now access ROI-based volumetrics, longitudinal reporting of Delta T1 and fractional tumor burden ("FTB") volumes, and standardized DICOM SR storage within a single, integrated environment. Expanded imaging capabilities-including ASL (arterial spin labeling), SAGE (spiral and gradient echo) perfusion, DCE enhancements, and diffusion MRI processing-deliver further insights, while user-centric features like color-blind support, customizable lookup tables, and automated reporting streamline interpretation and documentation. Combined with seamless integration across physical and cloud-based platforms, IB Clinic empowers users to achieve faster, more accurate results tailored to their unique clinical and research needs.

Behind the scenes, IB has implemented over 30 stability improvements and bug fixes, expanded support for Mac viewer platforms, and modernized its development pipeline with automated testing of parameter map generation. These operational upgrades ensure that IB Clinic continues to deliver reliability and scalability as adoption grows.

Timothy Dondlinger, COO of Imaging Biometrics, LLC, commented: "This release of IB Clinic represents a pivotal step in our mission to make advanced neuroimaging accessible, automated, and seamlessly integrated into diverse workflows. By combining automation with flexibility, we are empowering clinicians, researchers, and partners to accelerate discovery and improve patient outcomes."

--ENDS-

The Directors of the Company accept responsibility for the contents of this announcement.

For further information, please contact:

About Imaging Biometrics® LLC: IB is a wholly owned subsidiary of Imaging Biometrics Limited, (LON: IBAI), and focuses on delivering quantitative imaging platforms and therapeutics that transform how clinicians diagnose and treat patients more efficiently and effectively. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com. Follow IB on X, @ImgBiometrics.